Skip to main content
Mankind Pharma Limited logo

Mankind Pharma Limited — Investor Relations & Filings

Ticker · MANKIND ISIN · INE634S01028 LEI · 33580067G8AZ7S8NYA02 BSE.NS Manufacturing
Open in API
Filings indexed 397 across all filing types
Latest filing 2023-08-28 Environmental & Social …
Country IN India
Listing BSE.NS MANKIND

About Mankind Pharma Limited

https://www.mankindpharma.com/

Mankind Pharma Limited focuses on the development, manufacturing, and marketing of a broad spectrum of pharmaceutical formulations and consumer healthcare products. The company’s portfolio spans various therapeutic areas, including anti-infectives, cardiovascular, gastrointestinal, dermatology, and respiratory health. It maintains a significant presence in the over-the-counter segment with brands such as Manforce, Prega News, and Gas-O-Fast. The organization operates a robust research and development infrastructure dedicated to creating affordable and accessible medicinal solutions. Its operational model leverages an extensive distribution network to ensure product availability across diverse geographic regions, prioritizing high-quality healthcare delivery and patient-centric innovation.

Recent filings

Filing Released Lang Actions
Updates
Environmental & Social Information Classification · 100% confidence The document is titled 'Business Responsibility & Sustainability Report for FY 2022-23' and is submitted pursuant to SEBI regulations. It contains detailed disclosures about the company's environmental, social, and governance (ESG) practices, including employee data, CSR details, grievance mechanisms, and sustainability issues. The content focuses on the company's performance on environmental and social factors rather than financial results or governance structure. The document length is substantial (15,000 characters), indicating it is the report itself, not just an announcement. Therefore, it fits the category of Environmental & Social Information (SR).
2023-08-28 English
Shareholders meeting
AGM Information Classification · 95% confidence The document is a letter dated August 28, 2023, from Mankind Pharma Limited addressed to stock exchanges, enclosing the Annual Report for the financial year 2022-23 and the Notice of the 32nd Annual General Meeting (AGM). It references the Annual Report and AGM Notice being available on the company's website and sent to shareholders. The document includes detailed AGM agenda items such as adoption of audited financial statements, re-appointment of directors, and ratification of an employee stock option plan. The content is primarily the Notice of AGM and related resolutions, not the full Annual Report itself. The document length is 15,000 characters, but the text indicates it is a notice and announcement of the Annual Report and AGM, not the full report. According to the "Menu vs Meal" rule, since this document announces the Annual Report and AGM Notice and provides details about the meeting and resolutions, it fits best as AGM Information (AGM-R). It is not the full Annual Report (10-K) or a simple announcement of report publication (RPA). Therefore, the classification is AGM Information (AGM-R) with high confidence.
2023-08-28 English
Acquisition
Regulatory Filings Classification · 95% confidence The document is an official communication dated August 24, 2023, addressed to stock exchanges (BSE and NSE) regarding the approval by the Board of Directors to incorporate a wholly owned subsidiary. It references Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events by listed companies. The content includes detailed disclosure about the proposed subsidiary, including capital, business purpose, and shareholding. There is no financial data, earnings information, or report attached or referenced as being published. The document is an announcement of a corporate action (incorporation of a subsidiary) pursuant to regulatory disclosure requirements. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement that does not fit into more specific categories like capital changes or M&A filings. The document length (5336 characters) and content confirm it is not a brief report publication announcement or a full financial report.
2023-08-24 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) dated August 24, 2023, from Mankind Pharma Limited. It references the publication of a newspaper advertisement regarding the upcoming Annual General Meeting (AGM) scheduled for September 22, 2023, including information about e-voting. The content is about notifying the exchanges of the advertisement publication and AGM details, not the AGM materials themselves. The document is approximately 15,000 characters but primarily serves as an announcement of the AGM advertisement and related information, not the AGM presentation or materials. Therefore, it fits best under the category of AGM Information (AGM-R) as it relates to AGM communications, but since it is specifically about the advertisement and notice of the AGM, it is more accurately classified as a Regulatory Filing (RNS) because it is an announcement/notification rather than the AGM materials themselves. However, given the definitions, AGM Information (AGM-R) is for presentations and materials shared during the AGM, which this is not. The document is not a report or transcript but an official regulatory announcement about the AGM advertisement. Hence, the best fit is Regulatory Filings (RNS).
2023-08-24 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short communication dated August 3, 2023, addressed to stock exchanges and shareholders. It announces the availability of the audio recording of an investor conference call for Q1FY24, referencing a prior intimation about the call. The text does not contain any financial data or detailed transcript but only provides a link to the recording. The document is under 5,000 characters and serves as a notification rather than the full transcript or report itself. Therefore, it fits the category of a Call Transcript announcement or notification. However, since it only announces the availability of the audio recording and does not contain the transcript itself, it is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement about the call recording, not the transcript or report itself.
2023-08-03 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is dated August 3, 2023, and is addressed to stock exchanges in India (BSE and NSE). It references Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates the publication of financial results. The subject line states it is a "Newspaper Publication of Consolidated Unaudited Financial Results for the quarter ended June 30, 2023." The document includes extracts of the consolidated unaudited financial results for the quarter ended June 30, 2023, which is a quarterly period. The document is about the publication of financial results in newspapers, which is a regulatory requirement for listed companies in India. The document is not the full quarterly report but an announcement of the financial results publication. The length is 15,000 characters, which is substantial, but the content is primarily an announcement of the publication of the financial results extracts in newspapers, not the full interim report itself. Therefore, according to the "Menu vs Meal" rule, this is a Regulatory Filing (RNS) as it is a regulatory announcement of financial results publication, not the full interim/quarterly report containing substantive financial data and analysis.
2023-08-03 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.